Holen Sie sich die Stockscreener-App
102.50
0.14%
-0.14
Handel nachbörslich:
103.99
1.49
+1.45%
Schlusskurs vom Vortag:
$102.64
Offen:
$102.8
24-Stunden-Volumen:
5.86M
Relative Volume:
0.82
Marktkapitalisierung:
$151.88B
Einnahmen:
$18.49B
Nettoeinkommen (Verlust:
$2.51B
KGV:
61.01
EPS:
1.68
Netto-Cashflow:
$3.23B
1W Leistung:
-0.44%
1M Leistung:
-0.68%
6M Leistung:
-3.43%
1J Leistung:
+35.01%
1-Tages-Spanne:
$101.62
$103.07
1-Wochen-Bereich:
$101.62
$104.46
52-Wochen-Spanne:
$75.53
$108.53
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.51B | 3.23B | 1.68 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.98B | 6.78B | 7.98 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 4.14B | 577.90M | 6.96 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-16 | Hochstufung | Needham | Hold → Buy |
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
Structural Heart Devices Market Set to Expand and Reach ~USD 25 Billion by 2032 Amid Rising Demand for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Are Medical Stocks Lagging Boston Scientific (BSX) This Year? - Yahoo Finance
Fund Update: FLPUTNAM INVESTMENT MANAGEMENT CO added 95,234 shares of BOSTON SCIENTIFIC ($BSX) to their portfolio - Quiver Quantitative
3 Reasons Growth Investors Will Love Boston Scientific (BSX) - Yahoo Finance
Boston Scientific Corporation Is Expensive But Worth It - Seeking Alpha
Boston Scientific (NYSE:BSX) Is Experiencing Growth In Returns On Capital - ca.finance.yahoo.com
Boston Scientific updates instructions of devices linked to 17 deaths - MedTech Dive
Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue - Yahoo Finance
FDA says Watchman access alert remedied by review of IFU - BioWorld MedTech
FDA issues alert for updated instructions for certain Boston Scientific Watchman access systems - MassDevice
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths - MSN
Q2 Medical Devices & SuppliesDiversified Earnings: Boston Scientific (NYSE:BSX) Earns Top Marks - ca.finance.yahoo.com
Boston Scientific tells users about defibrillator problem linked to deaths, injuries - MedTech Dive
Oppenheimer Lifts Boston Scientific (BSX) PT to $118 Following Strong Q2 Results - Insider Monkey
Investors Heavily Search Boston Scientific Corporation (BSX): Here is What You Need to Know - Yahoo Finance
Boston Scientific survey reveals weight loss struggles among women, launches Endura procedures - MassDevice
Boston Scientific stock falls after FDA discloses defibrillation lead issue - Investing.com
Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions - Yahoo Finance
CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin - The Globe and Mail
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corporation Could See a Relief Rally From SupportDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
Investing in Boston Scientific (NYSE:BSX) Five Years Ago Would Have Delivered You a 170% Gain - 富途牛牛
Boston Scientific Second Quarter 2025 Earnings: Beats Expectations - ca.finance.yahoo.com
BOSTON SCIENTIFIC CORPORATION (BSX) - MSN
Boston Scientific Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Oppenheimer Adjusts Boston Scientific (BSX) Price Target After Q - GuruFocus
What are the latest earnings results for Boston Scientific CorporationCapitalize on emerging investment opportunities - Jammu Links News
What are Boston Scientific Corporation company’s key revenue driversMarket-beating returns - Jammu Links News
Truist Boosts Boston Scientific (BSX) Price Target After Strong Quarter - Insider Monkey
Chart Analysts Warn of Resistance Near Boston Scientific Corporation PriceGrowth Based Investment Plan Guidance Highlighted - metal.it
Boston Scientific earns Medicare reimbursement for Agent drug-coated balloon - MassDevice
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Yahoo Finance
Boston Scientific Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
Boston Scientific Director Fujimori Sells $310,377 Worth of Stock - AInvest
11 Best Medical Stocks to Buy According to Analysts - Insider Monkey
Boston Scientific warns of shock impedance with certain defibrillator leads - MassDevice
Boston Sci offers new neuromod treatments to European patients - BioWorld MedTech
Boston Scientific Corporation Reversal Rally May Surprise BearsOversold Bounce Stock Play Ideas Gain Attention - metal.it
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
1.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):